Zimmer Biomet Holdings Inc
Slēgts
SektorsVeselības aprūpe
89.97 2.76
Pārskats
Akcijas cenas izmaiņa
24h
Min
87.54
Max
90.5
Ienākumi | 99M 239M |
|---|---|
Pārdošana | -157M 2.1B |
P/E Sektora vidējais | 22.797 50.958 |
EPS | 2.09 |
Dividenžu ienesīgums | 1.1 |
Peļņas marža | 11.43 |
Darbinieki | 17,000 |
EBITDA | 84M 538M |
Rekomendācijas | Neitrāls |
|---|---|
Prognoze 12 mēnešiem | +7.02% upside |
Dividenžu ienesīgums Sektora vidējais | 1.10% 2.41% |
|---|---|
Nākamie ieņēmumi | 2026. g. 6. aug. |
Nākamais dividenžu datums | 2026. g. 31. jūl. |
Nākamais Ex dividenžu datums | 2026. g. 25. jūn. |
Tirgus kapitalizācija | -899M 17B |
|---|---|
Iepriekšējā atvēršanas cena | 87.21 |
Iepriekšējā slēgšanas cena | 89.97 |
Ziņu noskaņojums
By Acuity
50%
50%
146 / 342 Rangs Healthcare
Zimmer Biomet Holdings Inc Grafiks
Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.
Par Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.